Imports of Synthetic Opioid Restricted
02 December 2016
The Drug Enforcement Administration has issued a final order that temporarily schedules the synthetic opioid 3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide (also known as U-47700) and its isomers, esters, ethers, salts, and salts of isomers, esters and ethers into schedule I pursuant to the temporary scheduling provisions of the Controlled Substances Act. As a result, this substance is subject to the regulatory controls and administrative, civil and criminal sanctions applicable to the manufacture, distribution, reverse distribution, importation, exportation, research, conduct of instructional activities and chemical analysis, and possession of schedule I controlled substances. This order is effective 14 November and will be in effect for two years, with a possible extension of one year pending completion of the permanent scheduling process.
According to the DEA, available data and information indicate that U-47700 has a high potential for abuse, no currently accepted medical use in treatment in the United States, and a lack of accepted safety for use under medical supervision.
- Medical Supplies & Medicine
- North America